Splenic NKG2D confers resilience versus susceptibility in mice after chronic social defeat stress: beneficial effects of (R)-ketamine

Ketamine: A Paradigm Shift for Depression Research and Treatment

(2019) John H. Krystal et al.   NEURON

The NKG2D axis: an emerging target in cancer immunotherapy

(2019) Mariya Lazarova et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Neurobiology of Resilience: Interface Between Mind and Body

(2019) Flurin Cathomas et al.   BIOLOGICAL PSYCHIATRY

Resilience to chronic stress is associated with specific neurobiological, neuroendocrine and immune responses

(2019) Anand Gururajan et al.   BRAIN BEHAVIOR AND IMMUNITY

Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine

(2019) Lijia Chang et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective

(2019) Kenji Hashimoto   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Abnormal composition of gut microbiota is associated with resilience versus susceptibility to inescapable electric stress

(2019) Kai Zhang et al.   Translational Psychiatry

Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites

(2019) Chun Yang et al.   Translational Psychiatry

Antibiotic-induced microbiome depletion is associated with resilience in mice after chronic social defeat stress

(2019) Siming Wang et al.   JOURNAL OF AFFECTIVE DISORDERS

Mechanistic Target of Rapamycin–Independent Antidepressant Effects of ( R )-Ketamine in a Social Defeat Stress Model

(2018) Chun Yang et al.   BIOLOGICAL PSYCHIATRY

Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms

(2018) Panos Zanos et al.   PHARMACOLOGICAL REVIEWS

The Role of Natural Killer Group 2, Member D in Chronic Inflammation and Autoimmunity

(2018) Marina Babic et al.   Frontiers in Immunology

NKG2D and Its Ligands: “One for All, All for One”

(2018) Alessandra Zingoni et al.   Frontiers in Immunology

Resilience and immunity

(2018) Robert Dantzer et al.   BRAIN BEHAVIOR AND IMMUNITY

Lack of Opioid System in the Antidepressant Actions of Ketamine

(2018) Kai Zhang et al.   BIOLOGICAL PSYCHIATRY

Resilience priming: Translational models for understanding resiliency and adaptation to early life adversity

(2018) Amanda C. Kentner et al.   DEVELOPMENTAL PSYCHOBIOLOGY

An update on ketamine and its two enantiomers as rapid-acting antidepressants

(2018) Kai Zhang et al.   Expert Review of Neurotherapeutics

Social Stress Mobilizes Hematopoietic Stem Cells to Establish Persistent Splenic Myelopoiesis

(2018) Daniel B. McKim et al.   Cell Reports

Increased expression of inwardly rectifying Kir4.1 channel in the parietal cortex from patients with major depressive disorder

(2018) Zhongwei Xiong et al.   JOURNAL OF AFFECTIVE DISORDERS

NKG2D: A versatile player in the immune system

(2017) Vedrana Jelenčić et al.   IMMUNOLOGY LETTERS

Anti-NKG2D mAb: A New Treatment for Crohn’s Disease?

(2017) Kasper Vadstrup et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Spleen contributes to restraint stress induced changes in blood leukocytes distribution

(2017) Wei Jiang et al.   Scientific Reports

Possible role of the gut microbiota–brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model

(2017) Chun Yang et al.   Translational Psychiatry

Altered expression of BDNF, BDNF pro-peptide and their precursor proBDNF in brain and liver tissues from psychiatric disorders: rethinking the brain–liver axis

(2017) B Yang et al.   Translational Psychiatry

Bifidobacterium in the gut microbiota confer resilience to chronic social defeat stress in mice

(2017) Chun Yang et al.   Scientific Reports

Ketamine’s antidepressant action: beyond NMDA receptor inhibition

(2016) Kenji Hashimoto   EXPERT OPINION ON THERAPEUTIC TARGETS

Immune and Neuroendocrine Mechanisms of Stress Vulnerability and Resilience

(2016) Caroline Ménard et al.   NEUROPSYCHOPHARMACOLOGY

Letter to the Editor: R-ketamine: a rapid-onset and sustained antidepressant without risk of brain toxicity

(2016) K. Hashimoto   PSYCHOLOGICAL MEDICINE

Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression

(2015) Ji-chun Zhang et al.   PSYCHOPHARMACOLOGY

R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects

(2015) C Yang et al.   Translational Psychiatry

Regulation of Ligands for the NKG2D Activating Receptor

(2013) David H. Raulet et al.   Annual Review of Immunology

The Spleen in Local and Systemic Regulation of Immunity

(2013) Vincenzo Bronte et al.   IMMUNITY

R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine

(2013) Ji-chun Zhang et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Neurobiology of resilience

(2012) Scott J Russo et al.   NATURE NEUROSCIENCE

Neural Mechanisms of Stress Resilience and Vulnerability

(2012) Tamara B. Franklin et al.   NEURON

A standardized protocol for repeated social defeat stress in mice

(2011) Sam A Golden et al.   Nature Protocols

Altered NK Cell Development and Enhanced NK Cell-Mediated Resistance to Mouse Cytomegalovirus in NKG2D-Deficient Mice

(2009) Biljana Zafirova et al.   IMMUNITY

Stress and disorders of the stress system

(2009) George P. Chrousos   Nature Reviews Endocrinology

Psychobiology and molecular genetics of resilience

(2009) Adriana Feder et al.   NATURE REVIEWS NEUROSCIENCE

Repeated social defeat activates dendritic cells and enhances Toll-like receptor dependent cytokine secretion

(2008) Nicole D. Powell et al.   BRAIN BEHAVIOR AND IMMUNITY

NKG2D ligands: key targets of the immune response

(2008) Segundo González et al.   TRENDS IN IMMUNOLOGY